EI
MDGL icon

EFG International’s Madrigal Pharmaceuticals MDGL Stock Holding History

EFG International’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.36M Buy
9,980
+139
+1% +$71.2K 0.1% 181
2026
Q1 		$5.15M Sell
9,841
-532
-5% -$254K 0.11% 174
2025
Q4 		$6.05M Buy
+10,373
New +$5.3M 0.12% 149

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EFG International's MDGL Position: Q2 2026 in Review

EFG International increased its Madrigal Pharmaceuticals (MDGL) stake by 1.4% in Q2 2026, buying an estimated $71.2K and bringing the position to 9,980 shares worth $5.36M. The position accounts for 0.1% of the portfolio, ranked #181.

EFG International first reported a position in MDGL in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.05M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • EFG International held 9,980 shares of Madrigal Pharmaceuticals worth $5.36M as of Q2 2026.
  • EFG International bought 139 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $71.2K.
  • Madrigal Pharmaceuticals made up 0.1% of EFG International's portfolio in Q2 2026, its #181 holding.
  • EFG International first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • EFG International's Madrigal Pharmaceuticals position peaked at $6.05M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.